{"pmid":32268945,"title":"Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy?","text":["Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy?","This paper investigates the correlation between the high level of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) lethality and the atmospheric pollution in Northern Italy. Indeed, Lombardy and Emilia Romagna are Italian regions with both the highest level of virus lethality in the world and one of Europe's most polluted area. Based on this correlation, this paper analyzes the possible link between pollution and the development of acute respiratory distress syndrome and eventually death. We provide evidence that people living in an area with high levels of pollutant are more prone to develop chronic respiratory conditions and suitable to any infective agent. Moreover, a prolonged exposure to air pollution leads to a chronic inflammatory stimulus, even in young and healthy subjects. We conclude that the high level of pollution in Northern Italy should be considered an additional co-factor of the high level of lethality recorded in that area.","Environ Pollut","Conticini, Edoardo","Frediani, Bruno","Caro, Dario","32268945"],"abstract":["This paper investigates the correlation between the high level of Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) lethality and the atmospheric pollution in Northern Italy. Indeed, Lombardy and Emilia Romagna are Italian regions with both the highest level of virus lethality in the world and one of Europe's most polluted area. Based on this correlation, this paper analyzes the possible link between pollution and the development of acute respiratory distress syndrome and eventually death. We provide evidence that people living in an area with high levels of pollutant are more prone to develop chronic respiratory conditions and suitable to any infective agent. Moreover, a prolonged exposure to air pollution leads to a chronic inflammatory stimulus, even in young and healthy subjects. We conclude that the high level of pollution in Northern Italy should be considered an additional co-factor of the high level of lethality recorded in that area."],"journal":"Environ Pollut","authors":["Conticini, Edoardo","Frediani, Bruno","Caro, Dario"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32268945","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.envpol.2020.114465","keywords":["ARDS","Atmospheric pollution","Coronavirus","Covid-19","Inflammation"],"source":"PubMed","locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"weight":0,"_version_":1663620083195314177,"score":7.9164424,"similar":[{"pmid":32243592,"title":"Positive Externalities of an Epidemic: The Case of the Corona Virus (COVID-19) in China.","text":["Positive Externalities of an Epidemic: The Case of the Corona Virus (COVID-19) in China.","COVID-19 have undisputedly dented global economies as shown by indicators from the various stock markets. However, amidst these woes, China's quest to contain the spread of the pandemic and ultimately find its cure has resulted in some positive spillovers worth discussing. This commentary focuses on the positive effects that emanated from public policies and strategies enacted in China to control and ultimately to eradicate COVID-19. Specifically, these policies gave more room for testing futuristic technologies, reduce the spread of false information and pollution and provided social safety nets for affected individuals and firms. This article is protected by copyright. All rights reserved.","J Med Virol","Okyere, Michael Adu","Forson, Richmond","Essel-Gaisey, Felix","32243592"],"abstract":["COVID-19 have undisputedly dented global economies as shown by indicators from the various stock markets. However, amidst these woes, China's quest to contain the spread of the pandemic and ultimately find its cure has resulted in some positive spillovers worth discussing. This commentary focuses on the positive effects that emanated from public policies and strategies enacted in China to control and ultimately to eradicate COVID-19. Specifically, these policies gave more room for testing futuristic technologies, reduce the spread of false information and pollution and provided social safety nets for affected individuals and firms. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Okyere, Michael Adu","Forson, Richmond","Essel-Gaisey, Felix"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243592","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25830","keywords":["Coronavirus","Pandemic","Public Policy"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352135762313218,"score":178.05962},{"pmid":32277367,"title":"Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.","text":["Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.","The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern. Environmental factors such as air pollution and smoking and comorbid conditions (hypertension, diabetes mellitus and underlying cardio-respiratory illness) likely increase the severity of COVID-19. Rheumatic manifestations such as arthralgias and arthritis may be prevalent in about a seventh of individuals. COVID-19 can result in acute interstitial pneumonia, myocarditis, leucopenia (with lymphopenia) and thrombocytopenia, also seen in rheumatic diseases like lupus and Sjogren's syndrome. Severe disease in a subset of patients may be driven by cytokine storm, possibly due to secondary hemophagocytic lymphohistiocytosis (HLH), akin to that in systemic onset juvenile idiopathic arthritis or adult-onset Still's disease. In the absence of high-quality evidence in this emerging disease, understanding of pathogenesis may help postulate potential therapies. Angiotensin converting enzyme 2 (ACE2) appears important for viral entry into pneumocytes; dysbalance in ACE2 as caused by ACE inhibitors or ibuprofen may predispose to severe disease. Preliminary evidence suggests potential benefit with chloroquine or hydroxychloroquine. Antiviral drugs like lopinavir/ritonavir, favipiravir and remdesivir are also being explored. Cytokine storm and secondary HLH might require heightened immunosuppressive regimens. Current international society recommendations suggest that patients with rheumatic diseases on immunosuppressive therapy should not stop glucocorticoids during COVID-19 infection, although minimum possible doses may be used. Disease-modifying drugs should be continued; cessation may be considered during infection episodes as per standard practices. Development of a vaccine may be the only effective long-term protection against this disease.Key Points* Patients with coronavirus disease 19 (COVID-19) may have features mimicking rheumatic diseases, such as arthralgias, acute interstitial pneumonia, myocarditis, leucopenia, lymphopenia, thrombocytopenia and cytokine storm with features akin to secondary hemophagocytic lymphohistiocytosis.* Although preliminary results may be encouraging, high-quality clinical trials are needed to better understand the role of drugs commonly used in rheumatology like hydroxychloroquine and tocilizumab in COVID-19.* Until further evidence emerges, it may be cautiously recommended to continue glucocorticoids and other disease-modifying antirheumatic drugs (DMARDs) in patients receiving these therapies, with discontinuation of DMARDs during infections as per standard practice.","Clin Rheumatol","Misra, Durga Prasanna","Agarwal, Vikas","Gasparyan, Armen Yuri","Zimba, Olena","32277367"],"abstract":["The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern. Environmental factors such as air pollution and smoking and comorbid conditions (hypertension, diabetes mellitus and underlying cardio-respiratory illness) likely increase the severity of COVID-19. Rheumatic manifestations such as arthralgias and arthritis may be prevalent in about a seventh of individuals. COVID-19 can result in acute interstitial pneumonia, myocarditis, leucopenia (with lymphopenia) and thrombocytopenia, also seen in rheumatic diseases like lupus and Sjogren's syndrome. Severe disease in a subset of patients may be driven by cytokine storm, possibly due to secondary hemophagocytic lymphohistiocytosis (HLH), akin to that in systemic onset juvenile idiopathic arthritis or adult-onset Still's disease. In the absence of high-quality evidence in this emerging disease, understanding of pathogenesis may help postulate potential therapies. Angiotensin converting enzyme 2 (ACE2) appears important for viral entry into pneumocytes; dysbalance in ACE2 as caused by ACE inhibitors or ibuprofen may predispose to severe disease. Preliminary evidence suggests potential benefit with chloroquine or hydroxychloroquine. Antiviral drugs like lopinavir/ritonavir, favipiravir and remdesivir are also being explored. Cytokine storm and secondary HLH might require heightened immunosuppressive regimens. Current international society recommendations suggest that patients with rheumatic diseases on immunosuppressive therapy should not stop glucocorticoids during COVID-19 infection, although minimum possible doses may be used. Disease-modifying drugs should be continued; cessation may be considered during infection episodes as per standard practices. Development of a vaccine may be the only effective long-term protection against this disease.Key Points* Patients with coronavirus disease 19 (COVID-19) may have features mimicking rheumatic diseases, such as arthralgias, acute interstitial pneumonia, myocarditis, leucopenia, lymphopenia, thrombocytopenia and cytokine storm with features akin to secondary hemophagocytic lymphohistiocytosis.* Although preliminary results may be encouraging, high-quality clinical trials are needed to better understand the role of drugs commonly used in rheumatology like hydroxychloroquine and tocilizumab in COVID-19.* Until further evidence emerges, it may be cautiously recommended to continue glucocorticoids and other disease-modifying antirheumatic drugs (DMARDs) in patients receiving these therapies, with discontinuation of DMARDs during infections as per standard practice."],"journal":"Clin Rheumatol","authors":["Misra, Durga Prasanna","Agarwal, Vikas","Gasparyan, Armen Yuri","Zimba, Olena"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277367","week":"202015|Apr 06 - Apr 12","doi":"10.1007/s10067-020-05073-9","keywords":["COVID-19","Epidemiology","Hydroxychloroquine","Hypothesis","Immunity","Pathogenesis","Vaccines","Vitamin D"],"source":"PubMed","locations":["thrombocytopenia","Cytokine","myocarditis","leucopenia","lymphopenia","thrombocytopenia"],"topics":["Treatment"],"weight":1,"e_drugs":["lopinavir-ritonavir drug combination","Ibuprofen","tocilizumab","Hydroxychloroquine","Chloroquine","remdesivir","favipiravir"],"_version_":1663798882933407744,"score":159.27603},{"pmid":32121543,"title":"Eco-Virological Preliminary Study of Potentially Emerging Pathogens in Hedgehogs (Erinaceus europaeus) Recovered at a Wildlife Treatment and Rehabilitation Center in Northern Italy.","text":["Eco-Virological Preliminary Study of Potentially Emerging Pathogens in Hedgehogs (Erinaceus europaeus) Recovered at a Wildlife Treatment and Rehabilitation Center in Northern Italy.","The Western European Hedgehog (Erinaceus europaeus) is one of the four hedgehog species belonging to the genus Erinaceus. Among them, E. amurensis is extant in East Asia's areas only, whereas E. europaeus, E. roumanicus and E. concolor are mainly found in Europe. E. europaeus is endemically distributed from western to central and southern Europe, including Italy. Western European hedgehogs' ecological and feeding habits, along with their high population densities, notable synanthropic attitudes, frequent contacts with sympatric wild and domestic species, including humans, implicate the possible involvement of E. europaeus in the ecology of potentially emerging viruses, such as coronaviruses, influenza A and influenza D viruses, canine distemper virus, pestiviruses and Aujeszky's disease virus. We examined 24 E. europaeus individuals found injured in urban and rural areas of Northern Italy. Of the 24 fecal samples collected and tested for the above-mentioned pathogens by both PCR-based and virus isolation methods, 14 were found PCR-positive for betacoronaviruses belonging to lineage C and related to the known Erinaceus coronaviruses (EriCoVs), as determined by partial sequencing of the virus genome. Our findings suggest that hedgehogs could be considered natural reservoirs of CoVs, and also act as chronic shedding carriers of these potentially emerging RNA viruses.","Animals (Basel)","Delogu, Mauro","Cotti, Claudia","Lelli, Davide","Sozzi, Enrica","Trogu, Tiziana","Lavazza, Antonio","Garuti, Giacomo","Castrucci, Maria Rita","Vaccari, Gabriele","De Marco, Maria Alessandra","Moreno, Ana","32121543"],"abstract":["The Western European Hedgehog (Erinaceus europaeus) is one of the four hedgehog species belonging to the genus Erinaceus. Among them, E. amurensis is extant in East Asia's areas only, whereas E. europaeus, E. roumanicus and E. concolor are mainly found in Europe. E. europaeus is endemically distributed from western to central and southern Europe, including Italy. Western European hedgehogs' ecological and feeding habits, along with their high population densities, notable synanthropic attitudes, frequent contacts with sympatric wild and domestic species, including humans, implicate the possible involvement of E. europaeus in the ecology of potentially emerging viruses, such as coronaviruses, influenza A and influenza D viruses, canine distemper virus, pestiviruses and Aujeszky's disease virus. We examined 24 E. europaeus individuals found injured in urban and rural areas of Northern Italy. Of the 24 fecal samples collected and tested for the above-mentioned pathogens by both PCR-based and virus isolation methods, 14 were found PCR-positive for betacoronaviruses belonging to lineage C and related to the known Erinaceus coronaviruses (EriCoVs), as determined by partial sequencing of the virus genome. Our findings suggest that hedgehogs could be considered natural reservoirs of CoVs, and also act as chronic shedding carriers of these potentially emerging RNA viruses."],"journal":"Animals (Basel)","authors":["Delogu, Mauro","Cotti, Claudia","Lelli, Davide","Sozzi, Enrica","Trogu, Tiziana","Lavazza, Antonio","Garuti, Giacomo","Castrucci, Maria Rita","Vaccari, Gabriele","De Marco, Maria Alessandra","Moreno, Ana"],"date":"2020-03-04T11:00:00Z","year":2020,"_id":"32121543","week":"202010|Mar 02 - Mar 08","doi":"10.3390/ani10030407","keywords":["Betacoronavirus infection","Erinaceus coronavirus (EriCoV)","coronaviruses","hedgehogs","public health","wild animals"],"source":"PubMed","locations":["Italy","E.","Western European"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Transmission","Mechanism"],"weight":1,"_version_":1663352134303744000,"score":147.60835},{"pmid":32196933,"title":"Coronaviruses and immunosuppressed patients. The facts during the third epidemic.","text":["Coronaviruses and immunosuppressed patients. The facts during the third epidemic.","Following the outbreak in China, the Lombardy region of Italy has become one of the areas of highest incidence of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). As the outbreak grew to a pandemic, many centres worldwide raised the concern that immunocompromised patients may be at high risk of developing a severe respiratory disease called COVID-19. Unlike common viral agents (such as Adenovirus, Rhinovirus, Norovirus, Influenza, Respiratory Syncytial Virus), Coronaviruses have not shown to cause a more severe disease in immunosuppressed patients. For this family of viruses the host innate immune response appears the main driver of lung tissue damage during infection.","Liver Transpl","D'Antiga, Lorenzo","32196933"],"abstract":["Following the outbreak in China, the Lombardy region of Italy has become one of the areas of highest incidence of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). As the outbreak grew to a pandemic, many centres worldwide raised the concern that immunocompromised patients may be at high risk of developing a severe respiratory disease called COVID-19. Unlike common viral agents (such as Adenovirus, Rhinovirus, Norovirus, Influenza, Respiratory Syncytial Virus), Coronaviruses have not shown to cause a more severe disease in immunosuppressed patients. For this family of viruses the host innate immune response appears the main driver of lung tissue damage during infection."],"journal":"Liver Transpl","authors":["D'Antiga, Lorenzo"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32196933","week":"202012|Mar 16 - Mar 22","doi":"10.1002/lt.25756","keywords":["Coronavirus","SARS","SARS-CoV-2,COVID-19","children","immunosuppression","liver","transplantation","viral infection"],"source":"PubMed","locations":["Norovirus","Rhinovirus","China","Italy","Coronaviruses","Lombardy"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Mechanism"],"weight":1,"_version_":1663352133500534784,"score":138.91837},{"pmid":32146445,"title":"Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.","text":["Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.","As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease.","J Infect Dev Ctries","Porcheddu, Rossella","Serra, Caterina","Kelvin, David","Kelvin, Nikki","Rubino, Salvatore","32146445"],"abstract":["As of 28 February 2020, Italy had 888 cases of SARS-CoV-2 infections, with most cases in Northern Italy in the Lombardia and Veneto regions. Travel-related cases were the main source of COVID-19 cases during the early stages of the current epidemic in Italy. The month of February, however, has been dominated by two large clusters of outbreaks in Northern Italy, south of Milan, with mainly local transmission the source of infections. Contact tracing has failed to identify patient zero in one of the outbreaks. As of 28 February 2020, twenty-one cases of COVID-19 have died. Comparison between case fatality rates in China and Italy are identical at 2.3. Additionally, deaths are similar in both countries with fatalities in mostly the elderly with known comorbidities. It will be important to develop point-of-care devices to aid clinicians in stratifying elderly patients as early as possible to determine the potential level of care they will require to improve their chances of survival from COVID-19 disease."],"journal":"J Infect Dev Ctries","authors":["Porcheddu, Rossella","Serra, Caterina","Kelvin, David","Kelvin, Nikki","Rubino, Salvatore"],"date":"2020-03-09T11:00:00Z","year":2020,"_id":"32146445","week":"202011|Mar 09 - Mar 15","doi":"10.3855/jidc.12600","keywords":["*Case Fatality Rates","*Italy","*Novel coronavirus COVID-19","*SARS-CoV-19","*outbreak"],"source":"PubMed","locations":["Veneto","Milan","Italy","China"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1663352134151700480,"score":132.23936}]}